France· FR:69061176
KERAFILM, solution pour application cutanée
A medicinal product containing acide lactique + acide salicylique, registered in France by PIERRE FABRE MEDICAMENT.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACIDE LACTIQUE + ACIDE SALICYLIQUE
- Manufacturer
- PIERRE FABRE MEDICAMENT
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009325952041 flacon(s) en verre brun de 10 ml avec bouchon(s) applicateur polyéthylène
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acide lactique + acide salicylique in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBazuka gelDiomed Developments Ltd
- GermanyClabin NPerrigo Deutschland Gmbh
- United StatesCornexPella Pharmaceuticals Co. Ltd
- SpainANTIVERRUGAS ISDIN COLODIONIsdin S.A.
- IrelandSalactol CollodionDermal Laboratories (Ireland) Limited
- PolandAcerinAflofarm Farmacja Polska Sp. z o.o.
- SwedenVerruxin 200 mg/200 mg Kutan lösningKaro Pharma AS
- CzechiaDUOFILMSTADA Arzneimittel AG, Bad Vilbel
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Duofilm, W-Tropfen
- Czechia · Duofilm
- Germany · Clabin N, Clabin Plus
- Estonia · Duofilm
- Spain · Antiverrugas, Verufil
- United Kingdom (Northern Ireland) · Bazuka, Bazuka Treatment
- Ireland · Salactol, Salatac
- Italy · Duofilm 16,7% + 15% Collodio, Verunec
- Latvia · Duofilm
- Netherlands · Duofilm
- Poland · Abe, Acerin
- Portugal · Calicida Indiano
- Romania · Duofilm
- Sweden · Verruxin
- Slovakia · Duofilm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/281d42dd-09f7-4cd8-94b8-eeac8d41661c GET /v1/drugs/281d42dd-09f7-4cd8-94b8-eeac8d41661c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69061176",
"date_amm": "1996-01-05",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ACIDE LACTIQUE + ACIDE SALICYLIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour application",
"voies_administration": "cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about acide lactique + acide salicylique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.